Study Sheds New Light on RAS Inhibitors' Role for Advanced CKD

México Noticias Noticias

Study Sheds New Light on RAS Inhibitors' Role for Advanced CKD
México Últimas Noticias,México Titulares
  • 📰 Medscape
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 55%

Treatment with a RAS inhibitor is widely accepted as standard practice for slowing progression of CKD, but data have been inconsistent as to whether there is benefit to continuing RAS inhibition when patients develop advanced CKD. KidneyWk

Asked to comment, Janani Rangaswami, MD, who was not involved with the study, said:"The message from STOP ACEi is that there is no harm continuing RAS inhibitor treatment, so when feasible continue treatment" even when a patient's eGFR drops below 30 mL/min/1.73m"There has been a perception among nephrologists of harm from RAS inhibitors in these patients because they can cause hyperkalemia and may not help with CKD progression once eGFR is less than 30 mL/min/1.

"Current guidelines do not provide specific advice on whether to continue or stop ACE inhibitors or ARBs for advanced chronic kidney disease," they also note. In addition to the primary outcome, 62% of patients who stopped RAS inhibitor treatment and 56% of those who continued developed end-stage kidney disease or required renal-replacement therapy, which translated into an adjusted hazard ratio of 1.28 for this outcome among those who discontinued compared with those who continued, which was just short of significance .

Those who discontinued RAS-inhibitor treatment could receive any guideline-recommended antihypertensive agent that was not a RAS inhibitor, although adding a RAS inhibitor was permitted as a last treatment resort.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Medscape /  🏆 386. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Pfizer study says updated COVID boosters rev up protectionPfizer study says updated COVID boosters rev up protectionPfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies.
Leer más »

Genetically Modified Mosquitoes Help Cut Disease, Study ShowsGenetically Modified Mosquitoes Help Cut Disease, Study ShowsThe number of disease-carrying mosquitoes in a Brazilian city dropped by up to 96% after hundreds of genetically modified male mosquitoes were released, New Scientist reported. The U.K. biotech company Oxitec is releasing these male mosquitoes in other locations of the world to control illnesses that mosquitoes spread, such as dengue, malaria, and Zika.
Leer más »

Lifting less weight can lead to greater muscle growth: studyLifting less weight can lead to greater muscle growth: studyA groundbreaking new study has shown how you can increase muscle growth while spending half the amount of time in the gym.
Leer más »

Study Finds On-Street Lampost EV Chargers Are Lowest-Carbon SolutionStudy Finds On-Street Lampost EV Chargers Are Lowest-Carbon SolutionOn-street charging is considered the most likely solution to the dilemma of urban drivers who are unable to install chargers at their homes.
Leer más »

Social media users spend less time and lose trust in platforms when they encounter censorship: studySocial media users spend less time and lose trust in platforms when they encounter censorship: studyA study from The First and Fourteenth Institute found social media users trust platforms less if they see blocked or labeled content, and will even spend less time on the app.
Leer más »



Render Time: 2025-03-07 09:30:58